Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings Co (TSE:4928) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Noevir Holdings Co Forward PE Ratio Related Terms
Noevir Holdings Co Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co Forward PE Ratio Chart
Noevir Holdings Co Annual Data
Trend
2025-09
Forward PE Ratio
19.71
Noevir Holdings Co Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
20.60
18.36
18.06
19.71
19.57
18.83
TSE:4928 vs PG, CL, KVUE: Forward PE Ratio Comparison
For the Household & Personal Products subindustry, Noevir Holdings Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co Forward PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Noevir Holdings Co (TSE:4928) has a Forward PE Ratio of 21.54 as of Aug. 14, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Noevir Holdings Co and its competitors. According to the industry distribution chart, Noevir Holdings Co ranks #562 out of 747 companies in the Consumer Packaged Goods industry, placing it in the top 75.2%.
Is Noevir Holdings Co's Forward PE Ratio too high?
Noevir Holdings Co's current Forward PE Ratio is 21.54. The Consumer Packaged Goods industry median Forward PE Ratio is 14.72. Noevir Holdings Co's value of 21.54 is 46.3% above this industry median. Based on the distribution chart, Noevir Holdings Co ranks #562 out of 747 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Noevir Holdings Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's Forward PE Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #562 out of 747 companies for Forward PE Ratio. This places Noevir Holdings Co in the lower half of its industry. The industry median Forward PE Ratio is 14.72. Noevir Holdings Co's value of 21.54 is 46.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Consumer Packaged Goods company?
The median Forward PE Ratio among Consumer Packaged Goods companies is 14.72, based on 747 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Noevir Holdings Co's current Forward PE Ratio of 21.54 is 46.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Noevir Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median Forward PE Ratio is 14.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current Forward PE Ratio is 21.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Fairly Valued. The stock's GF Value™ is 円4,974.20, compared to a current price of 円4,825.00 — trading 3% below its estimated fair value. The current Forward PE Ratio is 21.54 and 46.3% above the Consumer Packaged Goods industry median of 14.72. Noevir Holdings Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current Forward PE Ratio is 21.54 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,825.00 is trading 3% below its estimated GF Value™ of 円4,974.20.
GuruFocus considers Noevir Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4928:
Forward PE Ratio: 21.54
GF Value™: 円4,974.20 vs. price of 円4,825.00 (3% below fair value)
Industry Position: 46.3% above the Consumer Packaged Goods median (#562 of 747)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
88GF Score
Get the complete analysis for TSE:4928
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
